These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31120856)

  • 1. Prostate cancer screening: guidelines review and laboratory issues.
    Filella X; Albaladejo MD; Allué JA; Castaño MA; Morell-Garcia D; Ruiz MÀ; Santamaría M; Torrejón MJ; Giménez N
    Clin Chem Lab Med; 2019 Sep; 57(10):1474-1487. PubMed ID: 31120856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practice of early detection of prostate cancer : Descriptive survey in preparation for the PSAInForm study].
    Simbrich A; Semjonow A; Donner-Banzhoff N; Hense HW
    Urologe A; 2018 Jun; 57(6):702-708. PubMed ID: 29671079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice.
    Ferraro S; Bussetti M; Panteghini M
    Clin Chem; 2021 Mar; 67(4):602-609. PubMed ID: 33619518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The level of evidence for the use of biomarkers in the early detection of prostate cancer].
    Lamy PJ; Gauchez AS; Salomon L; Haugh M; Ceraline J; Fulla Y; Georges A; Larré S; Loric S; Luporsi E; Martin PM; Mazerolles C; Molinié V; Mongiat-Artus P; Piffret J; Thuillier F; Perrin P; Rebillard X;
    Ann Biol Clin (Paris); 2016; 74(2):227-32. PubMed ID: 27029727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Li J; Zhao G; Hall IJ
    Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
    Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
    Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.
    Partin MR; Lillie SE; White KM; Wilt TJ; Chrouser KL; Taylor BC; Burgess DJ
    Health Expect; 2017 Aug; 20(4):779-787. PubMed ID: 27807905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.
    Lewis R; Hornberger B
    JAAPA; 2017 Aug; 30(8):51-54. PubMed ID: 28742748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen screening: a critical review of current research and guidelines.
    Robinson JG; Hodges EA; Davison J
    J Am Assoc Nurse Pract; 2014 Oct; 26(10):574-81. PubMed ID: 24399687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PROSTATE CANCER EARLY DETECTION USING PSA - CURRENT TRENDS AND RECENT UPDATES].
    Lavi A; Cohen M
    Harefuah; 2017 Mar; 156(3):185-188. PubMed ID: 28551942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prostate-specific antigen test.
    Roobol MJ
    Expert Opin Med Diagn; 2013 Sep; 7(5):423-6. PubMed ID: 23875974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
    Kell JS
    Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening.
    Ragsdale JW; Halstater B; Martinez-Bianchi V
    Prim Care; 2014 Jun; 41(2):355-70. PubMed ID: 24830612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.